Oxidative StressNCT07181889
Oxidative Stress and Antioxidant Enzyme Activities in Elite Female Turkish Cross-Country Skiers
An observational study of Oxidative Stress and Redox Imbalance, run by Duvenciler Anadolu Lİsesi at 1 site in Turkey (Türkiye).
Trial summary
This study is designed to investigate oxidative stress and antioxidant defense biomarkers in elite female cross-country skiers compared with sedentary women. Oxidative stress plays a central role in exercise adaptation, and the balance between reactive oxygen species production and antioxidant capacity can influence… Read more about this study
- Who is it for?
- Ages 15 to 20 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Oxidative Stress, Redox Imbalance, Exercise-Induced Physiological Stress
- How many people
- 34 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 12 Nov 2021to 25 Feb 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 20 years
- Women only
- Healthy volunteers accepted
- Child, Adult
Study population: This study included 34 healthy female participants: 17 elite cross-country skiers and 17 sedentary controls matched for age and BMI. All participants were aged 15-20 years and met strict inclusion and exclusion criteria to ensure a homogeneous sample.
Who may be able to join
- Female participants aged 15-20 years
- Members of the Turkish junior or senior national cross-country skiing team (for athlete group)
- Sedentary lifestyle, no regular exercise training within the past 6 months (for control group)
- Body mass index within normal range (18.5-24.9 kg/m²)
- No use of antioxidant or vitamin supplementation within the past 3 months
- Non-smoker and no alcohol consumption
- Voluntary participation with signed informed consent (and parental consent if under 18 years)
Who cannot join
- Presence of chronic metabolic, cardiovascular, or inflammatory diseases
- Current medication use affecting oxidative stress or metabolism
- Acute infection or illness within 2 weeks prior to data collection
- Recent musculoskeletal injury or inability to comply with testing procedures
- Failure to complete overnight fasting or rest requirements before blood sampling
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Muş Alparslan University, Faculty of Sports Sciences
Muş, Muş, 49250
About this study
This study is designed to investigate oxidative stress and antioxidant defense biomarkers in elite female cross-country skiers compared with sedentary women. Oxidative stress plays a central role in exercise adaptation, and the balance between reactive oxygen species production and antioxidant capacity can influence performance and recovery. Despite growing interest in redox biology, evidence from elite female endurance athletes is limited.
This cross-sectional observational study enrolled 17 elite female cross-country skiers, who were members of the Turkish national junior and senior teams, and 17 age- and BMI-matched sedentary women. All participants reported to the laboratory between 07:00 and 09:00 a.m. after an overnight fast. Anthropometric characteristics, including height, weight, and BMI, were measured under standardized conditions.
Read more
Venous blood samples were collected from the antecubital vein using aseptic technique. Serum was separated, stored at -80 °C, and analyzed for key redox biomarkers. Catalase (CAT) activity was measured spectrophotometrically using the method of Aebi, reduced glutathione (GSH) concentration was determined using Ellman's reagent, and malondialdehyde (MDA), a marker of lipid peroxidation, was assessed using the thiobarbituric acid reactive substances (TBARS) assay. All analyses were performed in triplicate in a certified clinical biochemistry laboratory.
The primary objective of this study is to characterize and compare systemic antioxidant capacity and oxidative stress levels between trained athletes and sedentary controls. The data generated will provide insight into how chronic endurance training in cold outdoor environments affects enzymatic and non-enzymatic antioxidant systems in young women.
Read the detailed description
This study was designed as a cross-sectional observational investigation to examine systemic oxidative stress and antioxidant defenses in elite female cross-country skiers compared with sedentary women of similar age and body mass index. The study followed the STROBE guidelines for reporting observational research and complied with the principles of the Declaration of Helsinki. Ethical approval was granted by the Muş Alparslan University Scientific Research and Publication Ethics Committee (Approval No: 27754; Date: 27 October 2021).
Participants
A total of 34 women participated in the study, including 17 elite female cross-country skiers who were current members of the Turkish national junior and senior teams (2021-2025 competitive seasons) and 17 sedentary women matched for age and BMI. Inclusion criteria were: (a) female sex; (b) age between 15-20 years; (c) absence of chronic metabolic, cardiovascular, or inflammatory diseases; (d) no regular medication use; (e) no vitamin or antioxidant supplementation within the preceding three months; and (f) non-smoker and non-alcohol consumer. Exclusion criteria included acute infection, recent musculoskeletal injury, or failure to comply with pre-test requirements (e.g., overnight fasting, rest). Written informed consent was obtained from all participants; for those under 18 years of age, parental or guardian consent was also collected.
Anthropometric and Pre-Analytical Procedures
All participants attended the laboratory between 07:00 and 09:00 a.m. following a 10-12-hour overnight fast to minimize the effect of circadian variation and dietary intake on oxidative stress markers. Upon arrival, participants were asked to remain seated in a quiet, temperature-controlled room (22-24 °C) for at least 30 minutes to achieve resting physiological conditions. Anthropometric measurements were taken barefoot and in light clothing using standardized procedures: standing height was measured to the nearest 0.1 cm using a stadiometer, and body weight was measured to the nearest 0.1 kg with a calibrated digital scale. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m²).
Blood Sampling and Processing
Venous blood samples (approximately 3 mL) were collected from the antecubital vein using sterile vacutainer tubes. Samples were allowed to clot for 20-30 minutes at room temperature and subsequently centrifuged at 5000 rpm for 10 minutes to separate serum. Serum aliquots were transferred into labeled polypropylene tubes and stored at -80 °C until biochemical analysis. Previous studies have confirmed the stability of oxidative stress biomarkers, including reactive oxygen metabolites and antioxidant potential, in serum stored under these conditions for up to five years.
Biochemical Analyses
All analyses were performed in the Central Biochemistry Laboratory of Van Yüzüncü Yıl University Faculty of Medicine by the same experienced laboratory technician to minimize inter-operator variability.
Catalase (CAT) activity was determined according to the spectrophotometric method of Aebi, which measures the rate of hydrogen peroxide decomposition at 240 nm over a two-minute interval at 25 °C. Results were expressed as units per milliliter (U/mL).
Reduced Glutathione (GSH) concentration was quantified using the colorimetric method of Beutler et al., employing Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid), DTNB) to produce a yellow-colored compound measurable at 412 nm.
Malondialdehyde (MDA) concentration, a marker of lipid peroxidation, was measured by the thiobarbituric acid reactive substances (TBARS) assay, based on the formation of a pink MDA-TBA complex read at 532 nm.
Each sample was analyzed in triplicate, and mean values were used for subsequent statistical processing to increase measurement reliability.
Data Management and Planned Analyses
Data were entered into a secure electronic database and cross-checked for accuracy by two independent researchers. Descriptive statistics (mean ± standard deviation, minimum-maximum) were calculated for all continuous variables. The normality of data distributions was assessed using the Shapiro-Wilk test. For variables not meeting the assumption of normality, non-parametric tests (Mann-Whitney U test) were pre-specified to compare group differences. Effect sizes were to be calculated using Cohen's d with 95% confidence intervals to quantify the magnitude of between-group differences. Correlations between CAT, GSH, and MDA were planned using Spearman rank-order correlation coefficients. Statistical significance was set at p < 0.05.
- Keywords
- Catalase, Glutathione, Malondialdehyde, Oxidative Stress Biomarkers, Endurance Training, Female Athletes, Sports Science
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Elite Cross-Country Skiers | Female athletes aged 15-20 years who are members of the Turkish junior or senior national cross-country skiing teams. Participants are engaged in regular endurance training and competition. No experimental intervention is applied; participants undergo anthropometric measurements and venous blood sampling for oxidative stress and antioxidant biomarker analysis. | |
| Sedentary Control Group | Healthy women aged 15-20 years, matched for age and BMI to the athlete group. Participants have no history of regular exercise training for at least 6 months prior to enrollment. No experimental intervention is applied; participants undergo the same anthropometric and blood sampling procedures as the athlete group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Serum Catalase (CAT) Activity
Catalase activity in serum measured spectrophotometrically at 240 nm following Aebi's method; expressed as units per milliliter (U/mL).
Measured: Baseline (single fasting blood draw)
Serum Reduced Glutathione (GSH) Concentration
Total glutathione concentration measured colorimetrically using Ellman's reagent (DTNB); expressed as µmol/L.
Measured: Baseline (single fasting blood draw)
Serum Malondialdehyde (MDA) Concentration
Marker of lipid peroxidation measured via thiobarbituric acid reactive substances (TBARS) method; expressed as nmol/mL.
Measured: Baseline (single fasting blood draw)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2025
- Study start12 Nov 2021
- Primary completion20 Feb 2022
- Study completion25 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Oxidative StressStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Duvenciler Anadolu Lİsesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Omer Faruk Bilici, Duvenciler Anadolu Lİsesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07181889
- Sponsor's protocol ID
- 27754
- Status last verified
- Sep 2025
- First submitted
- 12 Sep 2025
- Last updated
- 25 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because the dataset contains sensitive personal health information and the sample size is small, which may compromise participant confidentiality.
Publications
Seyhan S, Bilici MF, Demir H, Bilici OF, Kahraman MZ, Sahin MF, Aglar S, Soylu C, Acar G, Kizilca S. Oxidative stress and antioxidant enzyme activities in elite female Turkish cross-country skiers. BMC Sports Sci Med Rehabil. 2026 Apr 9;18(1):185. doi: 10.1186/s13102-026-01674-0.
PubMed 41957792
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oxidative Stress and Antioxidant Enzyme Activities in Elite Female Turkish Cross-Country Skiers
- ClinicalTrials.gov ID
- NCT07181889
- Acronym / sponsor ID
- 27754
- Keywords
- Catalase, Glutathione, Malondialdehyde, Oxidative Stress Biomarkers, Endurance Training, Female Athletes, Sports Science
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Duvenciler Anadolu LİsesiUniversity, hospital or other
- Study start
- 12 Nov 2021 (actual)
- Primary completion
- 20 Feb 2022 (actual)
- Study completion
- 25 Feb 2022 (actual)
- First posted
- 18 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is designed to investigate oxidative stress and antioxidant defense biomarkers in elite female cross-country skiers compared with sedentary women. Oxidative stress plays a central role in exercise adaptation, and the balance between reactive oxygen species production and antioxidant capacity can influence performance and recovery. Despite growing interest in redox biology, evidence from elite female endurance athletes is limited.
This cross-sectional observational study enrolled 17 elite female cross-country skiers, who were members of the Turkish national junior and senior teams, and 17 age- and BMI-matched sedentary women. All participants reported to the laboratory between 07:00 and 09:00 a.m. after an overnight fast. Anthropometric characteristics, including height, weight, and BMI, were measured under standardized conditions.
Venous blood samples were collected from the antecubital vein using aseptic technique. Serum was separated, stored at -80 °C, and analyzed for key redox biomarkers. Catalase (CAT) activity was measured spectrophotometrically using the method of Aebi, reduced glutathione (GSH) concentration was determined using Ellman's reagent, and malondialdehyde (MDA), a marker of lipid peroxidation, was assessed using the thiobarbituric acid reactive substances (TBARS) assay. All analyses were performed in triplicate in a certified clinical biochemistry laboratory.
The primary objective of this study is to characterize and compare systemic antioxidant capacity and oxidative stress levels between trained athletes and sedentary controls. The data generated will provide insight into how chronic endurance training in cold outdoor environments affects enzymatic and non-enzymatic antioxidant systems in young women.
Detailed description
This study was designed as a cross-sectional observational investigation to examine systemic oxidative stress and antioxidant defenses in elite female cross-country skiers compared with sedentary women of similar age and body mass index. The study followed the STROBE guidelines for reporting observational research and complied with the principles of the Declaration of Helsinki. Ethical approval was granted by the Muş Alparslan University Scientific Research and Publication Ethics Committee (Approval No: 27754; Date: 27 October 2021).
Participants
A total of 34 women participated in the study, including 17 elite female cross-country skiers who were current members of the Turkish national junior and senior teams (2021-2025 competitive seasons) and 17 sedentary women matched for age and BMI. Inclusion criteria were: (a) female sex; (b) age between 15-20 years; (c) absence of chronic metabolic, cardiovascular, or inflammatory diseases; (d) no regular medication use; (e) no vitamin or antioxidant supplementation within the preceding three months; and (f) non-smoker and non-alcohol consumer. Exclusion criteria included acute infection, recent musculoskeletal injury, or failure to comply with pre-test requirements (e.g., overnight fasting, rest). Written informed consent was obtained from all participants; for those under 18 years of age, parental or guardian consent was also collected.
Anthropometric and Pre-Analytical Procedures
All participants attended the laboratory between 07:00 and 09:00 a.m. following a 10-12-hour overnight fast to minimize the effect of circadian variation and dietary intake on oxidative stress markers. Upon arrival, participants were asked to remain seated in a quiet, temperature-controlled room (22-24 °C) for at least 30 minutes to achieve resting physiological conditions. Anthropometric measurements were taken barefoot and in light clothing using standardized procedures: standing height was measured to the nearest 0.1 cm using a stadiometer, and body weight was measured to the nearest 0.1 kg with a calibrated digital scale. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m²).
Blood Sampling and Processing
Venous blood samples (approximately 3 mL) were collected from the antecubital vein using sterile vacutainer tubes. Samples were allowed to clot for 20-30 minutes at room temperature and subsequently centrifuged at 5000 rpm for 10 minutes to separate serum. Serum aliquots were transferred into labeled polypropylene tubes and stored at -80 °C until biochemical analysis. Previous studies have confirmed the stability of oxidative stress biomarkers, including reactive oxygen metabolites and antioxidant potential, in serum stored under these conditions for up to five years.
Biochemical Analyses
All analyses were performed in the Central Biochemistry Laboratory of Van Yüzüncü Yıl University Faculty of Medicine by the same experienced laboratory technician to minimize inter-operator variability.
Catalase (CAT) activity was determined according to the spectrophotometric method of Aebi, which measures the rate of hydrogen peroxide decomposition at 240 nm over a two-minute interval at 25 °C. Results were expressed as units per milliliter (U/mL).
Reduced Glutathione (GSH) concentration was quantified using the colorimetric method of Beutler et al., employing Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid), DTNB) to produce a yellow-colored compound measurable at 412 nm.
Malondialdehyde (MDA) concentration, a marker of lipid peroxidation, was measured by the thiobarbituric acid reactive substances (TBARS) assay, based on the formation of a pink MDA-TBA complex read at 532 nm.
Each sample was analyzed in triplicate, and mean values were used for subsequent statistical processing to increase measurement reliability.
Data Management and Planned Analyses
Data were entered into a secure electronic database and cross-checked for accuracy by two independent researchers. Descriptive statistics (mean ± standard deviation, minimum-maximum) were calculated for all continuous variables. The normality of data distributions was assessed using the Shapiro-Wilk test. For variables not meeting the assumption of normality, non-parametric tests (Mann-Whitney U test) were pre-specified to compare group differences. Effect sizes were to be calculated using Cohen's d with 95% confidence intervals to quantify the magnitude of between-group differences. Correlations between CAT, GSH, and MDA were planned using Spearman rank-order correlation coefficients. Statistical significance was set at p < 0.05.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Elite Cross-Country Skiers | – | –Female athletes aged 15-20 years who are members of the Turkish junior or senior national cross-country skiing teams. Participants are engaged in regular endurance training and competition. No experimental intervention is applied; participants undergo anthropometric measurements and venous blood sampling for oxidative stress and antioxidant biomarker analysis. |
| Sedentary Control Group | – | –Healthy women aged 15-20 years, matched for age and BMI to the athlete group. Participants have no history of regular exercise training for at least 6 months prior to enrollment. No experimental intervention is applied; participants undergo the same anthropometric and blood sampling procedures as the athlete group. |
Who may qualify
- Ages
- 15 to 20 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- This study included 34 healthy female participants: 17 elite cross-country skiers and 17 sedentary controls matched for age and BMI. All participants were aged 15-20 years and met strict inclusion and exclusion criteria to ensure a homogeneous sample.
Key inclusion criteria (7 listed)
- Female participants aged 15-20 years
- Members of the Turkish junior or senior national cross-country skiing team (for athlete group)
- Sedentary lifestyle, no regular exercise training within the past 6 months (for control group)
- Body mass index within normal range (18.5-24.9 kg/m²)
- No use of antioxidant or vitamin supplementation within the past 3 months
Key exclusion criteria (5 listed)
- Presence of chronic metabolic, cardiovascular, or inflammatory diseases
- Current medication use affecting oxidative stress or metabolism
- Acute infection or illness within 2 weeks prior to data collection
- Recent musculoskeletal injury or inability to comply with testing procedures
- Failure to complete overnight fasting or rest requirements before blood sampling
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Serum Catalase (CAT) Activity
Time frame: Baseline (single fasting blood draw)
Catalase activity in serum measured spectrophotometrically at 240 nm following Aebi's method; expressed as units per milliliter (U/mL).
Serum Reduced Glutathione (GSH) Concentration
Time frame: Baseline (single fasting blood draw)
Total glutathione concentration measured colorimetrically using Ellman's reagent (DTNB); expressed as µmol/L.
Serum Malondialdehyde (MDA) Concentration
Time frame: Baseline (single fasting blood draw)
Marker of lipid peroxidation measured via thiobarbituric acid reactive substances (TBARS) method; expressed as nmol/mL.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2025.
- Derived from this study: PubMed 41957792Seyhan S, Bilici MF, Demir H, Bilici OF, Kahraman MZ, Sahin MF, Aglar S, Soylu C, Acar G, Kizilca S. Oxidative stress and antioxidant enzyme activities in elite female Turkish cross-country skiers. BMC Sports Sci Med Rehabil. 2026 Apr 9;18(1):185. doi: 10.1186/s13102-026-01674-0.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because the dataset contains sensitive personal health information and the sample size is small, which may compromise participant confidentiality.
Related trials for Oxidative Stress
Not yet recruitingObservational study
Periodontal Status and Biomarkers in MASLD
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
RecruitingPhase 1
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Adrenocortical Carcinoma (ACC), Recurrent Adrenocortical Carcinoma (ACC)
Recruiting
Acute Effects of Post-Exercise Hyperoxia on Recovery in Cycling
Athletic Performance, Hyperbaric Oxygenation
Recruiting
Dietary Intervention Study on Liver Health in Young Adults
Liver Health
RecruitingObservational study
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
Gaucher Disease Type I, Oxidative Stress
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Oxidative Stress and Redox Imbalance, run by Duvenciler Anadolu Lİsesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Serum Catalase (CAT) Activity (time frame: Baseline (single fasting blood draw)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07181889, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2025.